美国ASCO 年会拾贝:一种新型的组蛋白脱乙酰基酶抑制剂OSU-HDAC42对HER-2阳性乳腺癌有抗肿瘤作用

doi:10.3877/cma.j.issn.1674-0807.2009.05.016

中华乳腺病杂志(电子版) ›› 2009, Vol. 03 ›› Issue (05) : 568 -568. doi: 10.3877/cma.j.issn.1674-0807.2009.05.016

医学快讯

美国ASCO 年会拾贝:一种新型的组蛋白脱乙酰基酶抑制剂OSU-HDAC42对HER-2阳性乳腺癌有抗肿瘤作用

唐鹏¹, 范林军¹

1.400038 重庆,第三军医大学西南医院乳腺疾病中心

收稿日期:2009-09-18 出版日期:2009-10-01

Antitumor effects of OSU-HDAC42, a novel histone deacetylase inhibitor,in HER-2-positive breast cancer: information from ASCO

Peng TANG, Linjun Fan

Received:2009-09-18 Published:2009-10-01

全文 ( ) 下载PDF ( ) 导出引用

引用本文：

唐鹏, 范林军. 美国ASCO 年会拾贝:一种新型的组蛋白脱乙酰基酶抑制剂OSU-HDAC42对HER-2阳性乳腺癌有抗肿瘤作用[J/OL]. 中华乳腺病杂志(电子版), 2009, 03(05): 568-568.

Peng TANG, Linjun Fan. Antitumor effects of OSU-HDAC42, a novel histone deacetylase inhibitor,in HER-2-positive breast cancer: information from ASCO[J/OL]. Chinese Journal of Breast Disease(Electronic Edition), 2009, 03(05): 568-568.

选择文件类型/文献管理软件名称

选择包含的内容

Antitumor effects of OSU-HDAC42, a novel histone deacetylase inhibitor,in HER-2-positive breast cancer: information from ASCO

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

Antitumor effects of OSU-HDAC42, a novel histone deacetylase inhibitor,in HER-2-positive breast cancer: information from ASCO